4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide has been researched along with ANS (Autonomic Nervous System) Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukumoto, K; Kusumoto, M; Tsuchishita, Y; Ueno, K | 1 |
1 other study(ies) available for 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Effects of serum concentrations of disopyramide and its metabolite mono-N-dealkyldisopyramide on the anticholinergic side effects associated with disopyramide.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Autonomic Nervous System Diseases; Chromatography, High Pressure Liquid; Creatinine; Disopyramide; Female; Humans; Male; Middle Aged; Urination Disorders; Xerostomia | 2008 |